The reduction of SOX2 expression we found following SB747651A exposure could be linked to the decreased fraction of treated tumor cells with spheroid formation abilities, since SOX2 is a crucial stemness and self-renewal protein in glioblastomas. This evidence concerns the gene SOX2 and glioblastoma.